File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab

TitleCorrelation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab
Authors
Issue Date2013
Citation
Cancer Medicine, 2013, v. 2, p. 234-242 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/194850
ISSN
2023 Impact Factor: 2.9
2023 SCImago Journal Rankings: 1.174
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLiu, Yen_US
dc.contributor.authorStarr, MDen_US
dc.contributor.authorBulusu, Aen_US
dc.contributor.authorPang, HMHen_US
dc.contributor.authorWong, NSen_US
dc.contributor.authorHoneycutt, Wen_US
dc.contributor.authorAmara, Aen_US
dc.contributor.authorHurwitz, HIen_US
dc.contributor.authorNixon, ABen_US
dc.date.accessioned2014-02-17T02:14:43Z-
dc.date.available2014-02-17T02:14:43Z-
dc.date.issued2013en_US
dc.identifier.citationCancer Medicine, 2013, v. 2, p. 234-242en_US
dc.identifier.issn2045-7634-
dc.identifier.urihttp://hdl.handle.net/10722/194850-
dc.languageengen_US
dc.relation.ispartofCancer Medicineen_US
dc.titleCorrelation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumaben_US
dc.typeArticleen_US
dc.identifier.emailPang, HMH: herbpang@hku.hken_US
dc.identifier.authorityPang, HMH=rp01857en_US
dc.identifier.doi10.1002/cam4.71en_US
dc.identifier.pmid23634291-
dc.identifier.hkuros228016en_US
dc.identifier.volume2en_US
dc.identifier.spage234en_US
dc.identifier.epage242en_US
dc.identifier.isiWOS:000209210600012-
dc.identifier.issnl2045-7634-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats